Breaking barriers in HIV treatment: the game-changing impact of lenacapavir

Abstract

HIV is a lentivirus that selectively targets and infects CD4 cells, which are integral to the immune system. Through viral integration and replication, infected cells are gradually destroyed, leading to a weakened immune system and an increased susceptibility to illnesses. The HIV epidemic has resulted in approximately 40.1 million deaths and 84.2 million infections to date, with 38.4 million individuals living with HIV as of the end of 2021. The estimated global prevalence of HIV in adults aged 15 to 49 is 0.7%.